CRISPR-Edited Immune Effectors: The End of the Beginning

MOLECULAR THERAPY

卷 28, 期 4, 页码 995-996

CELL PRESS

-

Biotechnology & Applied Microbiology Genetics & Heredity Medicine, Research & Experimental

1. National Cancer Institute [P50CA126752]
2. SU2C/AACR Meg Vosburg T cell Lymphoma Dream Team, [604817]
3. Leukemia and Lymphoma Society